- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02649569
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer
Continuous Activity Monitoring During Fractionated Radiotherapy: A Pilot Study
연구 개요
상세 설명
PRIMARY OBJECTIVES:
I. To demonstrate the feasibility of continuous, accelerometer-based evaluation of patient activity levels before, during, and after treatment with fractionated external beam radiotherapy.
SECONDARY OBJECTIVES:
I. To demonstrate the feasibility of performing weekly quality of life assessments during fractionated external beam radiotherapy.
II. To explore how accelerometer-based metrics change throughout patients' treatment courses and if these changes are associated with quality of life assessments, treatment interruptions, hospitalizations, and clinical outcomes.
OUTLINE:
Patients wear an activity monitor throughout and up 4 weeks after completion of radiation therapy. Patients who are willing may continue to wear the monitor through routine follow up appointments. Patients also complete questionnaires at evaluations, which take place prior to radiotherapy initiation, weekly during radiotherapy, and then 2 and 4 weeks after the completion of radiotherapy.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
New York
-
Bronx, New York, 미국, 10461
- Albert Einstein College of Medicine
-
Bronx, New York, 미국, 10467-2490
- Montefiore Medical Center - Moses Campus
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Able to ambulate independently (without the assistance of a cane or walker)
- Diagnosis of invasive malignancy of the head and neck region, lung, or gastrointestinal tract
- Planned treatment with fractionated (>= 15 treatments) external beam radiotherapy with concurrent chemotherapy with curative intent
Women of childbearing potential must:
- Have a negative serum or urine pregnancy test within 72 hours prior to the start of study therapy
- Agree to utilize an adequate method of contraception throughout treatment and for at least 4 weeks after study therapy is completed
- Be advised of the importance of avoiding pregnancy during trial participation and the potential risks of an unintentional pregnancy
- All patients must sign study specific informed consent prior to study entry
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
---|---|
Observational (continuous activity monitoring, questionnaires)
Patients wear an activity monitor throughout and up 4 weeks after completion of radiation therapy.
Patients who are willing may continue to wear the monitor through routine follow up appointments.
Patients also complete questionnaires at evaluations, which take place prior to radiotherapy initiation, weekly during radiotherapy, and then 2 and 4 weeks after the completion of radiotherapy.
|
Wear activity monitor
다른 이름들:
Complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Number of patients who complete most (>= 80%) of the protocol-specified assessments
기간: Up to 4 weeks post-chemoradiation therapy
|
This pilot study will yield preliminary data on the feasibility of activity monitoring during radiotherapy as well as possible associations between activity level and various clinical and treatment-related variables.
Data from the study will be summarized using standard descriptive statistics; means and standard deviations will be used for normally-distributed continuous variables, and frequencies and percentages will be used for categorical variables.
Exploratory analyses for associations between activity levels and clinical and treatment-related variables will be performed using chi-square o
|
Up to 4 weeks post-chemoradiation therapy
|
Number of patients who successfully use the activity monitor (i.e. wearing the activity monitor throughout the treatment course)
기간: Up to 4 weeks post-chemoradiation therapy
|
This pilot study will yield preliminary data on the feasibility of activity monitoring during radiotherapy as well as possible associations between activity level and various clinical and treatment-related variables.
Data from the study will be summarized using standard descriptive statistics; means and standard deviations will be used for normally-distributed continuous variables, and frequencies and percentages will be used for categorical variables.
Exploratory analyses for associations between activity levels and clinical and treatment-related variables will be performed using chi-square o
|
Up to 4 weeks post-chemoradiation therapy
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Nitin Ohri, Albert Einstein College of Medicine
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2015-4873 (기타 식별자: Albert Einstein College of Medicine)
- P30CA013330 (미국 NIH 보조금/계약)
- NCI-2015-02292 (레지스트리 식별자: CTRP (Clinical Trial Reporting Program))
- 007067
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
소화기계암에 대한 임상 시험
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; West China Hospital; Third Affiliated Hospital, Sun Yat-Sen University 그리고 다른 협력자들모병간 종양 치료를 위한 Steep Pulse Therapy System중국
-
Thammasat UniversityNational Research Council of Thailand완전한2세에서 10세 사이의 경련성 마비가 있는 어린이 | GMFCS(Gross Motor Function Classification System) 레벨 I, II 및 III태국
Monitoring Device에 대한 임상 시험
-
Seoul National University HospitalSeoul National University모집하지 않고 적극적으로
-
Singapore General HospitalKK Women's and Children's Hospital; SingHealth Polyclinics완전한
-
Maquet Cardiopulmonary AG빼는
-
Bio-Medical Research, Ltd.완전한